Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-106,273
Closed -$1.91M 109
2016
Q1
$1.91M Sell
106,273
-1,175
-1% -$19K 0.36% 49
2015
Q4
$2.15M Buy
+107,448
New +$2.39M 0.4% 50
2015
Q2
$4.45M Buy
163,020
+11,250
+7% +$301K 0.76% 42
2015
Q1
$3.72M Sell
151,770
-400
-0.3% -$9.59K 0.68% 45
2014
Q4
$4.31M Sell
152,170
-3,900
-2% -$101K 0.78% 41
2014
Q3
$3.85M Buy
156,070
+142,120
+1,019% +$3.96M 0.73% 42
2014
Q2
$387K Buy
+13,950
New +$391K 0.07% 88

Other funds holding SPA

Kimelman & Baird's SPA Position: Q2 2016 in Review

Kimelman & Baird sold out of Sparton (SPA) in Q2 2016, closing a stake of 106,273 shares — an estimated $1.91M sold.

Kimelman & Baird first reported a position in SPA in Q2 2014 and held it in 7 quarters. The position peaked at $4.45M in Q2 2015. 74 funds tracked by Wall St. Rank hold SPA as of Q2 2016.

  • Kimelman & Baird reported no remaining Sparton position as of Q2 2016 after selling out during the quarter.
  • Kimelman & Baird sold 106,273 Sparton shares in Q2 2016, an estimated $1.91M.
  • Kimelman & Baird first reported a position in Sparton in Q2 2014 and held it in 7 quarters.
  • Kimelman & Baird's Sparton position peaked at $4.45M in Q2 2015.
  • 74 funds tracked by Wall St. Rank held Sparton as of Q2 2016.

Based on Kimelman & Baird's 13F filing for Q2 2016, filed 16 Aug 2016.